Rep. Richard Dean McCormick, a Republican member of the U.S. House of Representatives, disclosed the sale of shares in Procter & Gamble Company (PG) in a Periodic Transaction Report filed under the STOCK Act. The transaction, dated July 30, 2026, was executed by McCormick himself and valued between $1,001 and $15,000. The holding was disclosed as being held through a Growth Partners Roth IRA.
The STOCK Act requires members of Congress to publicly report trades like this one within 45 days, giving the public visibility into the personal financial activity of lawmakers alongside their legislative duties. A filing of this size and structure does not by itself indicate any particular strategy or motive on McCormick’s part, and there is no suggestion of wrongdoing tied to the disclosure.
An Insider Sale Follows Days Later
What makes this filing notable is its timing relative to activity inside Procter & Gamble itself. Company insider Matthew W. Janzaruk also reported selling PG shares, on August 6, 2026, a transaction that landed within 30 days of McCormick’s own disclosed sale. Janzaruk’s filing listed a value of $0, a detail sometimes associated with transactions tied to options exercises, gifts, or other non-standard structures rather than an open-market cash sale.
Taken together, the two filings show both a sitting member of Congress and a company insider disposing of PG shares within a roughly one-week window. Whois Buying Now tracks these overlapping disclosure patterns because they can highlight moments when multiple parties with access to different kinds of information — congressional, corporate, or otherwise — are making similar portfolio moves around the same stock, even if the reasons behind each transaction differ entirely.
This is not the only recent PG-related disclosure our site has covered. Just weeks earlier, we reported on Rep. David J. Taylor buying P&G stock as an insider sold PG shares, another instance of divergent trading activity around the same company. Readers following Procter & Gamble across both congressional and corporate disclosures may find the pattern of buying and selling worth watching as more filings come in over the following weeks.
As always, a Periodic Transaction Report reflects a legally mandated disclosure, not an endorsement or warning about the underlying stock. The amount ranges reported under the STOCK Act are broad by design, and the exact number of shares involved in McCormick’s sale, or the precise proceeds, are not made public in these filings.